4

OWNERSHIP DOCUMENT

Company: SELLAS Life Sciences Group, Inc.
Filed: December 5, 2022
Period of Report: December 5, 2022
Accession Number: 0001104659-22-124565

View Document ↗ View on SEC.gov ↗